DBDounia Baroudi

Dounia Baroudi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dounia Baroudi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    WearAware: A Wearable-Based Early Warning Framework for Out-of-Hospital Cardiac Risk Monitoring

    by Amal AlNaemi, Eniola Olaleye, Dounia Baroudi, Arfan Ahmed

    Sudden cardiac events often occur outside hospitals, where monitoring is limited. WearAware combines a smart patch, clinician portal, and AI alerts for remote cardiac monitoring. Initial ECG testing showed 82.7% accuracy, 86.4% recall, and 0.85 F1-score; clinical validation was beyond this study.

  • Open Access

    The Role of Artificial Intelligence in the Characterization and Outcome Prediction of Prostate Cancer: A Systematic Review

    by Shahd Aljoudi, Aasiya Khan, Iman Dajani, Minatullah Al-Ani, Michael Mina, Dounia Baroudi, Sama Al-Saffar, Souha Aouadi, Tarraf Torfeh, Rabih Hammoud, et al.

    Background/Objectives: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men globally. Radiation oncologists often find PCa tumor characterization and outcome prediction challenging. Therefore, the potential for artificial intelligence (AI) implementation in radiation oncology has increased in recent years. This systematic review aims to evaluate the efficacy of AI algorithms in characterizing PCa tumors and predicting post-therapy outcomes. Methods: A total of 2055 studies were identified through a comprehensive search across PubMed and Scopus, then exported to Covidence. Inclusion criteria focused on prospective and retrospective cohort studies as well as randomized clinical trials (RCTs) published between 2015 and 2024 that explored the implementation of AI in tumor characterization and outcome prediction of PCa. Two independent reviewers evaluated each paper, and evaluation metrics such as specificity, sensitivity, accuracy, and area under the curve (AUC) were analyzed. The Risk of Bias in Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) tool was used to assess the risk of bias (ROB). Results: Across the 19 studies analyzed, there was no significant difference in model performance between machine learning (ML) and deep learning (DL) models. AI models using multi-input strategies (e.g., radiomics with clinical markers) generally performed better than single-input models. Of the imaging modalities used for radiomic feature extraction, multiparametric MRI (mpMRI)-trained AI models consistently achieved the highest performance. Conclusions: AI displays considerable potential for integration into clinical workflows for PCa management. However, further studies utilizing larger datasets and external cohorts independent of the sample population are needed to validate clinical utility and improve model transparency for reliable implementation.